Skip to main content

Ultra Pure Peptides - Research Use Only - Raw Material Sourced from the USA

Tesamorelin + CJC-1295 + Ipamorelin

Tesamorelin + CJC-1295 + Ipamorelin

$129.00

SKU: tesamorelin-CJC-1295-ipamorelin Categories: , , ,

Pickup available at Islip

Usually ready in 24 hours

View store information

Tesamorelin + CJC-1295 + Ipamorelin

Islip

Pickup available, usually ready in 24 hours

3 Grant Ave.
Ste. B
Islip NY 11751
United States
+16316770030

This combination of three growth hormone secretagogues—Tesamorelin, CJC-1295, and Ipamorelin—synergistically stimulates endogenous growth hormone (GH) and insulin-like growth factor 1 (IGF-1) secretion. Tesamorelin is FDA-approved and clinically proven to reduce visceral fat. CJC-1295 is a GHRH analog that promotes pulsatile GH release, while Ipamorelin is a selective GHRP (ghrelin receptor agonist) known for stimulating GH without raising cortisol or prolactin. Together, this trio enhances anabolic recovery, fat loss, tissue regeneration, and anti-aging effects.

Applications
  • Reduction of visceral (belly) fat
  • Muscle tone improvement and post-exercise recovery
  • Anti-aging and longevity enhancement
  • Improved sleep quality
  • Skin, joint, and hair health
  • Metabolic optimization (e.g., insulin sensitivity, fat metabolism)
  • Endogenous GH and IGF-1 stimulation
Mechanism of Action

Tesamorelin – GHRH Analog: Stimulates pituitary GH release and increases IGF-1 while specifically targeting visceral fat metabolism
CJC-1295 – Extended GHRH Activity: Mimics endogenous GHRH to promote rhythmic GH release and physiological hormone cycling
Ipamorelin – GHRP (Ghrelin Receptor Agonist): Selectively stimulates GH without triggering stress hormones like cortisol or prolactin
Synergistic Action: Combined use maximizes GH output while maintaining normal feedback control, mimicking natural circadian rhythms

Key Research Studies

1. Tesamorelin – Visceral Fat Reduction

  • Study: NEJM, 2010
  • Focus: Tesamorelin in HIV-related lipodystrophy
  • Findings: Clinically significant reduction in visceral fat
  • Link

2. Tesamorelin – Metabolic and IGF-1 Markers

  • Study: J Clin Endocrinol Metab, 2012
  • Findings: Improved IGF-1 and favorable metabolic effects
  • Link

3. CJC-1295 – GH and IGF-1 Secretion

  • Study: J Clin Endocrinol Metab, 2006
  • Focus: Healthy adult GH stimulation
  • Findings: Sustained elevation of GH and IGF-1 with pulsatile release
  • Link

4. Ipamorelin – Selective GH Release

  • Study: J Pharmacol Exp Ther, 1998
  • Findings: Increases GH without impacting prolactin or cortisol
  • Link
  • PubMed Summary

Biological Effects and Benefits

Increased GH & IGF-1

Stimulates natural production for regenerative and metabolic benefits

Fat Loss (Visceral):

Stimulates natural production for regenerative and metabolic benefits

Improved Muscle Tone & Recovery:

GH supports repair, collagen synthesis, and protein retention

Enhanced Sleep Quality:

CJC-1295 and Ipamorelin boost GH release during deep sleep

Biological Effects Image

Tissue Regeneration:

Supports skin, joint, and connective tissue repair via collagen and elastin synthesis

Metabolic Optimization:

Enhances insulin sensitivity and energy regulation

Anti-Aging Support:

Helps preserve youthful hormone levels and physiological function

Molecular Structure

Molecular Structure
  • Tesamorelin: Synthetic analog of GHRH with stabilized structure for longer half-life
  • CJC-1295: GHRH analog, often with DAC for prolonged activity
  • Ipamorelin: Selective GHRP, mimics ghrelin at the GH receptor
  • Combined Structure Notes: Each peptide targets distinct yet complementary aspects of GH release—hypothalamic (GHRH) and pituitary (ghrelin mimetic)

Related products